Analyst firms · J.P. Morgan · GTHX
J.P. Morgan GTHX price target and rating history
G1 Therapeutics Inc. (GTHX) · Health Care
J.P. Morgan rates G1 Therapeutics Inc. (GTHX) Neutral with a $10 price target, as of its latest action on Jan 30, 2023. It has published 3 rating actions on GTHX since September 2021, including 1 upgrade and 2 downgrades.
- Current rating
- Neutral
- Price target
- $10
- Median target, all firms
- Too few
- Actions on GTHX
- 3
J.P. Morgan price target on GTHX
Every J.P. Morgan rating on GTHX
- Jan 30, 2023
- Nov 4, 2021
- Sep 30, 2021
Questions about J.P. Morgan and GTHX
- What is J.P. Morgan's price target for GTHX?
- J.P. Morgan's latest stated price target for G1 Therapeutics Inc. (GTHX) is $10, from its action on Jan 30, 2023.
- What is J.P. Morgan's rating on GTHX?
- J.P. Morgan rates GTHX Neutral, a neutral rating, as of Jan 30, 2023.
- When did J.P. Morgan last change its view on GTHX?
- On Jan 30, 2023, J.P. Morgan upgrades to Neutral from Underweight, price target $7 to $10.
All J.P. Morgan ratingsGTHX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.